About BCIL
BCIL is a company based in Delhi (India). Laboratory training is provided to biotechnology students through exams. It operates on a B2B model. The company has 28 employees. Its Indian entity Biotech Consortium India Limited reported revenue of ₹6.12 Cr.
Company details
Biotech Consortium India Limited (BCIL) operates from Delhi, India, in the biotechnology education sector. Training programs in various biotechnology fields are delivered to students. An annual examination is administered to identify candidates for industrial placements. Opportunities for hands-on experience are arranged in government and private laboratories across the country. The domain bcil.nic.in serves as the official online presence.
- Headquarters Delhi, India
- Employees 28
- Website bcil.nic.in
- Legal Name Biotech Consortium India Limited
- Date of Incorporation 14 Sep, 1990
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹6.12 Cr
FY 2025 · +7% YoY
- Net Profit₹5.1 Lakh
FY 2025 · 1% margin
- EBITDA₹11.5 Lakh
FY 2025 · 2% margin
- Employee Count28
Associated legal entities of BCIL
BCIL operates through Biotech Consortium India Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biotech Consortium India Limited CIN U73100DL1990PLC041486 | Active | 14 Sep 1990 | New Delhi, Delhi | ₹6.1 Cr | 28 | 12 | View details |
Board of directors of Biotech Consortium India Limited (BCIL)
Biotech Consortium India Limited is the primary company behind BCIL. The board of Biotech Consortium India Limited currently have 11 directors; the longest-serving is Purnima Sharma, appointed in 2005. 31 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Purnima Sharma DIN 01082972 | Managing Director | 21 Nov 2005 | 20 yrs 11 mo | Biotech Consortium India Limited |
| Phadnis Ramarao Suresh DIN 01530411 | Nominee Director | 06 Sep 2011 | 15 yrs 1 mo | Biotech Consortium India Limited |
| Anita Gupta DIN 08271414 | Nominee Director | 01 Nov 2018 | 7 yrs 11 mo | Biotech Consortium India Limited |
| Sanjeev Khosla DIN 08906958 | Nominee Director | 28 Oct 2020 | 6 yrs | Biotech Consortium India Limited |
| Ram Vishwakarma Asrey DIN 07108315 | Additional Director | 28 Oct 2020 | 6 yrs | Biotech Consortium India Limited |
| Tilak Raj Sharma DIN 07163299 | Nominee Director | 30 Mar 2021 | 5 yrs 6 mo | Biotech Consortium India Limited |
| Ranjan Kumar Rath DIN 09735227 | Nominee Director | 28 Sep 2022 | 4 yrs 1 mo | Biotech Consortium India Limited |
| Shekhar Chintamani Mande DIN 10083454 | Additional Director | 02 Apr 2024 | 2 yrs 6 mo | Biotech Consortium India Limited |
| Sanghamitra Pati DIN 10835276 | Nominee Director | 13 Nov 2024 | 1 yr 11 mo | Biotech Consortium India Limited |
| Shashank Dixit DIN 08029761 | Nominee Director | 08 May 2025 | 1 yr 5 mo | Biotech Consortium India Limited |
| Smita Kumar DIN 11089210 | Nominee Director | 08 May 2025 | 1 yr 5 mo | Biotech Consortium India Limited |
Financials of BCIL
Figures of Biotech Consortium India Limited, the primary company behind BCIL, for FY 2025. Revenue was ₹6.12 Cr (+7% year on year). Net profit was ₹5.1 Lakh (1% margin). EBITDA was ₹11.5 Lakh (2% margin). Revenue has grown at a compounded annual rate of +2% over three years and -12% over five years.
- ₹6.12 CrRevenue · FY 2025 · +7% YoY
- ₹5.1 LakhNet profit · 1% margin
- ₹11.5 LakhEBITDA · 2% margin
- ₹5.37 CrPaid-up capital
- 28Employees (provident fund records)
- +2%Revenue CAGR, 3 years
- -12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Biotech Consortium India Limited are on its company page.
Detailed financial statements for BCIL
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bcil
Complete news archive for BCIL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BCIL
BCIL is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
BCIL has 28 employees.
The primary company behind BCIL, Biotech Consortium India Limited, reported revenue of ₹6.12 Cr for FY 2025, up 7% year on year.
Biotech Consortium India Limited (BCIL) operates from Delhi, India, in the biotechnology education sector. Training programs in various biotechnology fields are delivered to students. An annual examination is administered to identify candidates for industrial placements. Opportunities for hands-on experience are arranged in government and private laboratories across the country. The domain bcil.nic.in serves as the official online presence.
BCIL operates through Biotech Consortium India Limited.
The legal entities of BCIL currently have 12 directors, including Sanjeev Khosla, Shashank Dixit, Mukesh Gupta and others.